Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) CFO Robert Thomas Freeman sold 6,744 shares of the business’s stock in a transaction on Thursday, March 27th. The stock was sold at an average price of $17.89, for a total transaction of $120,650.16. Following the completion of the sale, the chief financial officer now owns 1,464,419 shares in the company, valued at approximately $26,198,455.91. The trade was a 0.46 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Robert Thomas Freeman also recently made the following trade(s):
- On Tuesday, March 18th, Robert Thomas Freeman sold 13,815 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.89, for a total value of $233,335.35.
- On Wednesday, March 12th, Robert Thomas Freeman sold 14,692 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total value of $226,697.56.
- On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total value of $3,390,121.35.
- On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.58, for a total transaction of $3,895,000.00.
Alignment Healthcare Price Performance
ALHC opened at $18.30 on Friday. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The business has a fifty day moving average of $15.28 and a 200 day moving average of $12.97. Alignment Healthcare, Inc. has a 52-week low of $4.46 and a 52-week high of $18.44. The stock has a market cap of $3.51 billion, a P/E ratio of -23.77 and a beta of 1.49.
Institutional Trading of Alignment Healthcare
Wall Street Analysts Forecast Growth
ALHC has been the subject of a number of recent research reports. Piper Sandler lifted their price objective on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 4th. Bank of America lifted their price target on Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. William Blair restated an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. JPMorgan Chase & Co. lifted their target price on Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, March 6th. Finally, Barclays increased their price target on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $14.83.
Check Out Our Latest Analysis on Alignment Healthcare
About Alignment Healthcare
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Featured Articles
- Five stocks we like better than Alignment Healthcare
- Most Volatile Stocks, What Investors Need to Know
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Options Trading – Understanding Strike Price
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to Invest in the Best Canadian Stocks
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.